MRNA

From a company barely known outside industry circles a year ago, Moderna (MRNA) has now become a household...

Shares of Moderna spiked 6.5% on Wednesday after the European Union authorized the use of its vaccine to...

Moderna announced that Israel’s Ministry of Health has granted authorization for the use of its COVID-19 vaccine (mRNA-1273)....

Moderna announced that Canada has authorized the use of its COVID-19 vaccine for the immunization of people aged...

Last week, Moderna’s (MRNA) Covid-19 vaccine candidate mRNA-1273 became the second approved vaccine in the U.S. after it...

Translate Bio on Dec. 22 announced that its CFO John Schroer will leave his post the end of...

Hot on the heels of the FDA granting EUA (emergency use authorization) for Pfizer/BioNTech’s Covid-19 vaccine BNT162b2, last...

Moderna announced on Friday that the U.S. Food and Drug Administration (FDA) has approved the emergency use of...

Last week, Moderna (MRNA) kicked off its TeenCOVE Study, dosing the first participants in the Phase 2/3 trial...

Favorable updates on potential COVID-19 vaccines have been a major catalyst for stock market movements in recent months....

Moderna has inked a deal to supply the US with another 100 million doses of its COVID-19 vaccine...

Moderna (MRNA) stock has been one of 2020’s star performers, up 695%, and judging by its real-world results,...

Roche has partnered with Moderna Inc. to use its anti-SARS-CoV-2 S antibody test in mRNA-1273 vaccine research trials....

Future study books will linger long and hard on the tumultuous events of 2020. Among the mountains of...

Shares of Moderna surged 10% on Thursday after it revealed subjects in the Phase 1 study led by...

Merck & Co. said it divested its direct equity investment in Moderna in the first half of the...

At the outset of 2020, Moderna (MRNA) was hardly a household name. But with 2021 in plain sight,...

Moderna announced that it will file for US and European emergency use of its COVID-19 vaccine candidate on...

Moderna has sealed a deal with the UK government for the supply of another 2 million doses of...

After what can only be described as a tumultuous year, with 2021 at the gate, both Wall Street...

Moderna has inked a deal to supply European Union countries with up to 160 million doses of its...

The past couple of weeks have seen extremely promising developments in the Covid-19 vaccine space. Both Pfizer (PFE)/BioNTech...

With winter at the gate and Covid-19 raging hard, the possibility the pandemic might soon be tamed got...

Shares of Moderna spiked 15% in Monday’s pre-market session as the company disclosed that its vaccine candidate, mRNA-1273,...

Moderna said it has collated sufficient data for the first interim analysis of the Phase 3 study of...

Joe Biden is now the President-elect, but in contrast to a prior Trump statement, the coronavirus is far...

And just like that, Election Day has come and gone. After Americans took to the polls, Wall Street...

Vaccine specialist Moderna (MRNA) reported its fiscal Q3 2020 financial results Thursday morning. Let’s run down the basic...

Moderna disclosed that it has received $1.1 billion in cash payments for the supply of its COVID-19 vaccine...

Moderna (MRNA) has announced a new supply deal with Qatar for mRNA-1273, Moderna’s vaccine candidate against COVID-19. Moderna...

Moderna (MRNA) has announced the initiation of a rolling submission to Health Canada for mRNA-1273, the company’s vaccine...

Vaccine specialist and COVID-19 antagonist Moderna (MRNA) had a busy Thursday, issuing press releases and holding conference calls...

It’s been a couple of week now since SVB Leerink analyst Mani Foroohar cited worries about increased competition...

mRNA specialist Moderna (MRNA) is among the leading players in the race to be first to market with...

Moderna (MRNA) has taken the rare step of publishing the clinical protocols for its late-stage Covid-19 vaccine trials. The...

Moderna stock (MRNA) is up 2.7% in Thursday’s pre-market trading after the company inked a deal with Vertex...

The world needs a vaccine against COVID-19, and with some 200 vaccine candidates in various stages of development,...

Leading the charge towards development of a COVID-19 vaccine proved very profitable for unprofitable biotech Moderna (MRNA) this...

Shares in Moderna dropped almost 4% on Friday, after its CEO told CNBC that the company was slowing...

Moderna confirmed that it is engaged in discussions with the Ministry of Health, Labour and Welfare of Japan (MHLW) to potentially purchase...

In the midst of a pandemic that has seen entire industries (airlines, rental cars, hotels) gutted, and others...

Moderna disclosed on Wednesday that its mRNA vaccine candidate (mRNA-1273) against COVID-19 demonstrated robust immune responses in older...

mRNA vaccine maker Moderna (MRNA) has undoubtably been one of 2020’s success stories. One of the frontrunners in...

Shares in Moderna (MRNA) spiked 11% in Tuesday’s after-hours trading after the company announced a $1.525 billion supply...

The narrative surrounding COVID-19-focused pharma companies is developing a new tone. While none of the players involved in...

The race to be first to market with a COVID-19 vaccine is changing gears. As the companies developing...

Moderna said it received $400 million of cash in deposits for the supply of its potential mRNA-1273 coronavirus...

Moderna (MRNA) is undoubtedly one of 2020’s success stories. Its rise has rested on the hope it can...

On Sunday, Moderna (MRNA) disclosed it had been awarded an extra $472 million from the Biomedical Advanced Research...

Moderna (MRNA) is seeking to charge between $50 to $60 for a course of its coronavirus vaccine mRNA-1273,...